- Tytuł:
- AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
- Autorzy:
- Źródło:
- BMC cancer [BMC Cancer] 2020 Jul 22; Vol. 20 (1), pp. 683. Date of Electronic Publication: 2020 Jul 22.
- Typ publikacji:
- Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
- MeSH Terms:
-
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents /*administration & dosageAntineoplastic Agents , Immunological/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Bevacizumab/*administration & dosage
Camptothecin/*analogs & derivatives
Colorectal Neoplasms/*drug therapy
Aged ; Camptothecin/administration & dosage ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Drug Administration Schedule ; Fluorouracil/administration & dosage ; Humans ; Italy ; Leucovorin/administration & dosage ; Microsatellite Instability ; Organoplatinum Compounds/administration & dosage ; Prospective Studies - SCR Protocol:
- FOLFOXIRI protocol
Czasopismo naukowe